| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Hansen Gwenn is a Chief Scientific Officer at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $3.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,847 | $23.38 | $89,953.63 | -3.1% | - | - | |
| Jun 25, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sell | 5,394 | $20.00 | $107,880.00 | -4.5% | - | - | |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,214 | $16.65 | $53,497.99 | -2.6% | +41.3% | - | |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 4,895 | $16.60 | $81,249.16 | -2.8% | +1.1% | - | |
| Oct 30, 2025 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 4,087 | $12.80 | $52,300.11 | -5.1% | +39.8% | - | |
| Jul 30, 2025 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 4,308 | $12.01 | $51,743.39 | -5.9% | +0.2% | - | |
| Apr 30, 2025 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,377 | $11.50 | $38,841.24 | -5.2% | +3.1% | +44.8% | |
| Jan 30, 2025 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,690 | $19.85 | $73,259.85 | -3.2% | -42.4% | -17.5% | |
| Oct 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,437 | $24.31 | $83,536.29 | -6.4% | -18.7% | -46.9% | |
| Jul 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,408 | $20.67 | $70,435.52 | -7.0% | +27.3% | -42.8% |